Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study (Q43694841)

From Wikidata
Jump to navigation Jump to search
scientific article published in September 2008
edit
Language Label Description Also known as
English
Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study
scientific article published in September 2008

    Statements

    Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study (English)
    I Florescu
    M Beuran
    A Razbadauskas
    M Bochan
    G Fichev
    G Dukart
    T Babinchak
    C A Cooper
    E J Ellis-Grosse
    N Dartois
    H Gandjini
    307 Study Group
    1 September 2008
    62 Suppl 1
    i17-28

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit